233 related articles for article (PubMed ID: 18045815)
1. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
[TBL] [Abstract][Full Text] [Related]
2. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
Günal AI; Celiker H; Dönder E; Günal SY
J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
[TBL] [Abstract][Full Text] [Related]
3. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
[TBL] [Abstract][Full Text] [Related]
4. Insulin action on protein metabolism in acromegalic patients.
Battezzati A; Benedini S; Fattorini A; Losa M; Mortini P; Bertoli S; Lanzi R; Testolin G; Biolo G; Luzi L
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E823-9. PubMed ID: 12388147
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.
Ikizler TA
J Ren Nutr; 2007 Jan; 17(1):13-6. PubMed ID: 17198926
[TBL] [Abstract][Full Text] [Related]
7. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
[TBL] [Abstract][Full Text] [Related]
8. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients.
Duranay M; Akay H; Yilmaz FM; Senes M; Tekeli N; Yücel D
Nephrol Dial Transplant; 2006 Nov; 21(11):3211-4. PubMed ID: 16861734
[TBL] [Abstract][Full Text] [Related]
9. Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients.
Barazzoni R; Zanetti M; Stulle M; Mucci MP; Pirulli A; Dore F; Panzetta G; Vasile A; Biolo G; Guarnieri G
Clin Nutr; 2008 Feb; 27(1):142-9. PubMed ID: 17854954
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients.
González-Ortiz M; Hernández-González SO; Hernández-Salazar E; Martínez-Abundis E
Ann Nutr Metab; 2008; 52(4):335-8. PubMed ID: 18714152
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance of protein metabolism in type 2 diabetes.
Pereira S; Marliss EB; Morais JA; Chevalier S; Gougeon R
Diabetes; 2008 Jan; 57(1):56-63. PubMed ID: 17940118
[TBL] [Abstract][Full Text] [Related]
12. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
[TBL] [Abstract][Full Text] [Related]
13. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of nocturnal haemodialysis on carnitine metabolism.
Hothi DK; Geary DF; Fisher L; Chan CT
Nephrol Dial Transplant; 2006 Sep; 21(9):2637-41. PubMed ID: 16822785
[TBL] [Abstract][Full Text] [Related]
15. The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients.
Suchitra MM; Ashalatha VL; Sailaja E; Rao AM; Reddy VS; Bitla AR; Sivakumar V; Rao PV
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1155-9. PubMed ID: 22089773
[TBL] [Abstract][Full Text] [Related]
16. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
17. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery.
Biolo G; De Cicco M; Lorenzon S; Dal Mas V; Fantin D; Paroni R; Barazzoni R; Zanetti M; Iapichino G; Guarnieri G
Crit Care Med; 2008 Jun; 36(6):1768-75. PubMed ID: 18496366
[TBL] [Abstract][Full Text] [Related]
18. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
Cibulka R; Racek J; Pikner R; Rajdl D; Trefil L; Vesela E; Studenovska M; Siroka R
Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
[TBL] [Abstract][Full Text] [Related]
19. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Reuter SE; Faull RJ; Evans AM
Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
Fornasini G; Upton RN; Evans AM
Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
